Company Report
Last edited 11 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#106
Performance (18m)
-29.3% pa
Followed by
7
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#ASX Announcements
stale
Added 11 months ago

Key points from DOC Statement Released 28th Feb:

  • FY21 YOY Revenue Growth of 115%, 132% CAGR since 2019
  • FY21 YOY Consults Growth of 105%
  • Guidance for FY22 expected to be 40-50%
  • Run-rate EBITDA profitability expected by end of 1H23 end
  • Launch of enhanced patient journey system
  • AU$11.2M institutional capital raising @ $0.31 to fund through to end of 1H23 when EBITDA profitability
  • SPP to raise ~ AU$1M (booklets dispatched March 7)
  • Advised in negotiations for acquisition opportunities, primarily in the UK